Plus   Neg

Alexion Pharmaceuticals Inc. Q3 adjusted earnings Beat Estimates

Alexion Pharmaceuticals Inc. (ALXN) released earnings for its third quarter that rose from last year.

The company's profit totaled $330.9 million, or $1.47 per share. This compares with $78.0 million, or $0.35 per share, in last year's third quarter.

Excluding items, Alexion Pharmaceuticals Inc. reported adjusted earnings of $460.1 million or $2.02 per share for the period.

Analysts had expected the company to earn $1.74 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 19.8% to $1.03 billion from $0.86 billion last year.

Alexion Pharmaceuticals Inc. earnings at a glance:

-Earnings (Q3): $460.1 Mln. vs. $328.3 Mln. last year.
-EPS (Q3): $2.02 vs. $1.44 last year.
-Analysts Estimate: $1.74
-Revenue (Q3): $1.03 Bln vs. $0.86 Bln last year.

Full year EPS guidance: $7.45 to $7.60
Full year revenue guidance: $4,020 to $4,050 Mln

For comments and feedback contact: editorial@rttnews.com

Follow RTT